<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01817816</url>
  </required_header>
  <id_info>
    <org_study_id>CCH-061203</org_study_id>
    <nct_id>NCT01817816</nct_id>
  </id_info>
  <brief_title>Early Injection of Botulinum Toxin on Motor Function and Gait Pattern in Stroke Patients</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Changhua Christian Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Changhua Christian Hospital</source>
  <brief_summary>
    <textblock>
      Spasticity, muscle weakness, abnormal gait pattern are co-morbidities commonly seen in stroke
      patients. They cause disabled condition of patients in activities of daily life and
      functional performance, and also accidental falls and subsequent fractures.

      This study is to evaluate and compare the effects of different phase injection of Botulinum
      Toxin Type-A at affected limbs on muscle rheological changes, muscle activity, muscle tone,
      functional performance, gait pattern and energy consumption in stroke patients.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2009</start_date>
  <completion_date type="Actual">June 2015</completion_date>
  <primary_completion_date type="Actual">April 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in the muscle tone in upper and lower extremity</measure>
    <time_frame>4 weeks after injection</time_frame>
    <description>use modified Ashworth Scale to access elbow, wrist, ankle joint muscle tone 0: normal
slight hypertonus, at the end-range 1+: mild hypertonus, catch when limb is moved (&lt;1/2)
moderate hypertonus,, limbs moves easily (&gt;1/2)
passive movement difficult
rigid</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in the gait pattern as walking</measure>
    <time_frame>4 weeks after intervention</time_frame>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">80</enrollment>
  <condition>Stroke</condition>
  <condition>Spasticity</condition>
  <arm_group>
    <arm_group_label>Botox_A</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>receiving Botulinum Toxin Type-A (Botox-A, Allergan) at both affected lower extremity (aLE) and upper extremity (aUE)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>placebo_A</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>receiving placebo injection at both aLE &amp; aUE ; receiving Botox-A at both aLE &amp; aUE at 6-month.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Botox_B</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>receiving Botox-A injection at aLE and placebo injection (sterile normal saline) at aUE.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>placebo_B</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>receiving placebo injection at both aLE &amp; aUE ; receiving Botox-A only at aLE at 6-month.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Botox_A</intervention_name>
    <arm_group_label>Botox_A</arm_group_label>
    <arm_group_label>placebo_A</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Botox_B</intervention_name>
    <arm_group_label>Botox_B</arm_group_label>
    <arm_group_label>placebo_B</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  first-ever stroke, with spasticity within 3-months (MAS=2~3)

          -  independent walking 10 meters (with assistive devices)

        Exclusion Criteria:

          -  recurrent stroke, cognition impaired

          -  lower limb fracture

          -  received anti-spasticity injection in the past
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>45 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Changhua Christian Hospital</name>
      <address>
        <city>Taiwan</city>
        <state>Changhua</state>
        <zip>500</zip>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Taiwan</country>
  </location_countries>
  <verification_date>November 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 21, 2013</study_first_submitted>
  <study_first_submitted_qc>March 21, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 25, 2013</study_first_posted>
  <last_update_submitted>November 3, 2015</last_update_submitted>
  <last_update_submitted_qc>November 3, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 5, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Changhua Christian Hospital</investigator_affiliation>
    <investigator_full_name>Ta-Sen Wei,MD</investigator_full_name>
    <investigator_title>Director, Physical Medical and Rehabilitation, Principal Investigator, Clinical Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stroke</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Botulinum Toxins</mesh_term>
    <mesh_term>onabotulinumtoxinA</mesh_term>
    <mesh_term>Botulinum Toxins, Type A</mesh_term>
    <mesh_term>abobotulinumtoxinA</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

